BGAC.F Stock Overview
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods and beverages with a focus on oligosaccharides.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
BioNeutra Global Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.061 |
52 Week High | CA$0.061 |
52 Week Low | CA$0.013 |
Beta | 1.95 |
1 Month Change | 0% |
3 Month Change | 360.23% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -41.59% |
Recent News & Updates
Recent updates
Shareholder Returns
BGAC.F | US Food | US Market | |
---|---|---|---|
7D | 0% | -0.2% | -3.7% |
1Y | n/a | -13.2% | 20.2% |
Return vs Industry: Insufficient data to determine how BGAC.F performed against the US Food industry.
Return vs Market: Insufficient data to determine how BGAC.F performed against the US Market.
Price Volatility
BGAC.F volatility | |
---|---|
BGAC.F Average Weekly Movement | n/a |
Food Industry Average Movement | 5.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BGAC.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BGAC.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Jianhua Zhu | www.bioneutra.ca |
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods and beverages with a focus on oligosaccharides. The company’s lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that provides low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers through direct-to-consumer retail channels, as well as through online retailers in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia.
BioNeutra Global Corporation Fundamentals Summary
BGAC.F fundamental statistics | |
---|---|
Market cap | US$3.56m |
Earnings (TTM) | -US$3.42m |
Revenue (TTM) | US$8.18m |
0.4x
P/S Ratio-1.0x
P/E RatioIs BGAC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BGAC.F income statement (TTM) | |
---|---|
Revenue | CA$11.27m |
Cost of Revenue | CA$10.08m |
Gross Profit | CA$1.19m |
Other Expenses | CA$5.90m |
Earnings | -CA$4.71m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.10 |
Gross Margin | 10.54% |
Net Profit Margin | -41.80% |
Debt/Equity Ratio | -93.1% |
How did BGAC.F perform over the long term?
See historical performance and comparison